Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited

Expression of EGFRvIII in Glioblastoma: Prognostic Significance Revisited

The epidermal growth factor receptor variant III (EGFRvIII) is associated with increased proliferation of glioma cells. However, the impact of EGFRvIII on survival of patients with glioblastoma (GBM) has not been definitively established. In the present study, we prospectively evaluated 73 patients...

Full description

Bibliographic Details
Main Authors:	Nicola Montano, Tonia Cenci, Maurizio Martini, Quintino Giorgio D’Alessandris, Federica Pelacchi, Lucia Ricci-Vitiani, Giulio Maira, Ruggero De Maria, Luigi Maria Larocca, Roberto Pallini
Format:	Article
Language:	English
Published:	Elsevier 2011-12-01
Series:	Neoplasia: An International Journal for Oncology Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1476558611800989

Similar Items

The natural history of EGFR and EGFRvIII in glioblastoma patients
by: Shi Weiming, et al.
Published: (2005-10-01)

Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma
by: Emily ePadfield, et al.
Published: (2015-01-01)

GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Alphonse, M.P, et al.
Published: (2022)

GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma
by: Alphonse, M.P, et al.
Published: (2022)

Quantitative analysis of the EGFRvIII mutant receptor signaling networks in Glioblastoma
by: Huang, Hua Ming Paul
Published: (2009)

EGFRvIII: An Oncogene with Ambiguous Role
by: Adrianna Rutkowska, et al.
Published: (2019-01-01)

Development of an EGFRvIII specific recombinant antibody
by: Li Gordon, et al.
Published: (2010-10-01)

A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII
by: Oberlies Nicholas H, et al.
Published: (2007-04-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)

Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
by: Jennifer P. Newman, et al.
Published: (2017-12-01)

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
by: Joseph S. Durgin, et al.
Published: (2021-05-01)

Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells
by: Xingmei Zhang, et al.
Published: (2018-03-01)

EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
by: Stefanie Keller, et al.
Published: (2017-06-01)

Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma.
by: Ayguen Sahin, et al.
Published: (2018-01-01)

Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
by: Maxime Fontanilles, et al.
Published: (2020-04-01)

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
by: Raghupathy Vengoji, et al.
Published: (2019-06-01)

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
by: Maurizio Martini, et al.
Published: (2018-05-01)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
by: Rebecca C Abbott, et al.
Published: (2021-01-01)

Novel high‐affinity EGFRvIII‐specific chimeric antigen receptor T cells effectively eliminate human glioblastoma
by: Rebecca C Abbott, et al.
Published: (2021-01-01)

Challenges in EGFRvIII detection in head and neck squamous cell carcinoma.
by: Sarah E Wheeler, et al.
Published: (2015-01-01)

Engineered superparamagnetic iron oxide nanoparticles (SPIONs) for dual-modality imaging of intracranial glioblastoma via EGFRvIII targeting
by: Xianping Liu, et al.
Published: (2019-09-01)

The biological and clinical significance of EGFR, EGFRvIII and IGF-IR in colorectal cancer
by: Cunningham, Matthew Paul
Published: (2005)

Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice
by: Muhua Chen, et al.
Published: (2019-05-01)

LncRNAs and EGFRvIII sequestered in TEPs enable blood-based NSCLC diagnosis
by: Luo CL, et al.
Published: (2018-06-01)

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
by: Kristina Ellwanger, et al.
Published: (2017-05-01)

Dilation of Brain Veins and Perivascular Infiltration by Glioblastoma Cells in an In Vivo Assay of Early Tumor Angiogenesis
by: Quintino Giorgio D’Alessandris, et al.
Published: (2021-01-01)

Generation of fusion protein EGFRvIII-HBcAg and its anti-tumor effect in vivo
by: Zhang Ming-xin, et al.
Published: (2009-09-01)

TNFα inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFα signaling
by: Li Ma, et al.
Published: (2019-09-01)

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
by: Bryan D. Choi, et al.
Published: (2019-11-01)

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.
by: Hongsheng Miao, et al.
Published: (2014-01-01)

An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing Glioblastoma Cells
by: Naegle, Kristen Marie, et al.
Published: (2011)

Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
by: You Li, et al.
Published: (2020-08-01)

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
by: Vidyalakshmi Chandramohan, et al.
Published: (2019-05-01)

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma
by: Kai Huang, et al.
Published: (2019-09-01)

Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.
by: Jessica E C Jones, et al.
Published: (2017-01-01)

A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity.
by: Lauren Zebertavage, et al.
Published: (2019-01-01)

Point Mutations in Retargeted gD Eliminate the Sensitivity of EGFR/EGFRvIII-Targeted HSV to Key Neutralizing Antibodies
by: Ceren Tuzmen, et al.
Published: (2020-03-01)

EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
by: Xiaoying Luo, et al.
Published: (2013-01-01)

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism
by: Juliana Gomez, et al.
Published: (2021-03-01)

Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
by: Tsutomu Nakazawa, et al.
Published: (2020-04-01)